Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M3BB
|
|||
| Former ID |
DIB004227
|
|||
| Drug Name |
Synthetic hypericin
|
|||
| Synonyms |
Hypericin; VIMRxyn; Synthetic hypericin, Nexell
Click to Show/Hide
|
|||
| Indication | Virus infection [ICD-11: 1A24-1D9Z] | Phase 3 | [1] | |
| Company |
Nexell Therapeutics Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein kinase C (PRKC) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02448381) Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides). U.S. National Institutes of Health. | |||
| REF 2 | Characterization of the interaction of hypericin with protein kinase C in U-87 MG human glioma cells. Photochem Photobiol. 2006 May-Jun;82(3):720-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.